Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




In-Cell Test for Papillomavirus

By HospiMedica staff writers
Posted on 08 Jan 2001
A fast test developed for papillomavirus (HPV) detects transforming genes, while current tests only detect the presence or absence of HPV but not the activity of transforming genes.

HPV has been implicated in the development of cervical cancer due to transforming genes, which are believed responsible for transforming normal cells into abnormal and potentially cancerous cells. More...
The new test is compatible with conventional Pap tests, liquid-based cytology specimens, and a new test under development that uses biomolecular marker probes. Based on technology licensed from Invirion (Frankfort, MI, USA), the test is the product of Ampersand Medical Corp. (Chicago, IL, USA) and is a companion product to Ampersand's InPath System.

The InPath System, based on biomolecular markers and fluorescence, represents a revolutionary approach to cervical cancer screening, says Ampersand. The system includes the use of multiple protein-based probes and stains used in combinations that are able to detect low-grade as well as high-grade dysplasia and cancer. InPath together with the new HPV test will offer a complete two-in-one, point-of-care screening system for cervical cancer.

"The combination of this HPV test and our InPath System is designed to keep cells intact, unlike other HPV screening options,” notes Peter Gombrich, chairman and CEO of Ampersand Medical. "This will enable pathologists and clinicians to determine cause-and-effect relationships between HPV and the presence of other diseases and symptoms, such as cervical cancer.”



Related Links:
Ampersand Medical

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Tourniquet System
heidi– mein Tourniquet
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.